Rybelsus vs Januvia: Oral GLP-1 vs DPP4 Comparison (Weight Loss, A1C, Cost)

Rybelsus and Januvia are two widely prescribed oral medications for adults with type 2 diabetes, but they belong to fundamentally different drug classes. Rybelsus (oral semaglutide), manufactured by Novo Nordisk, is a GLP-1 receptor agonist the first of its kind available as an oral tablet rather than an injection. Januvia (sitagliptin), produced by Merck, is […]